Matches in Nanopublications for { ?s ?p "[Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_assertion description "[Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402118.RAv11Yu376C2uJY3aT1tcrkwughBXLeJzmiugGkupHD18130_provenance.
- NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion description "[Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_provenance.